nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Drift, Evolution, and Divergence in Biologics and Biosimilars Manufacturing
|
Ramanan, Sundar |
|
2014 |
28 |
4 |
p. 363-372 |
artikel |
2 |
Human Immunoglobulin 10 % with Recombinant Human Hyaluronidase: Replacement Therapy in Patients with Primary Immunodeficiency Disorders
|
Sanford, Mark |
|
2014 |
28 |
4 |
p. 411-420 |
artikel |
3 |
Multi-Specific Antibodies for Cancer Immunotherapy
|
Jachimowicz, Ron D. |
|
2014 |
28 |
4 |
p. 331-343 |
artikel |
4 |
Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody–Drug Conjugates
|
Sauerborn, Melody |
|
2014 |
28 |
4 |
p. 383-391 |
artikel |
5 |
Purification, Characterization and Plasma Half-Life of PEGylated Soluble Recombinant Non-HA-Binding CD44
|
Pink, Anne |
|
2014 |
28 |
4 |
p. 393-402 |
artikel |
6 |
Ranibizumab: A Review of its Use in Myopic Choroidal Neovascularization
|
Deeks, Emma D. |
|
2014 |
28 |
4 |
p. 403-410 |
artikel |
7 |
siRNA Technology in Kidney Transplantation: Current Status and Future Potential
|
Glebova, Kristina |
|
2014 |
28 |
4 |
p. 345-361 |
artikel |
8 |
Targeting the PI3K/Akt/mTOR Pathway in Malignancy: Rationale and Clinical Outlook
|
Cho, Daniel C. |
|
2014 |
28 |
4 |
p. 373-381 |
artikel |
9 |
Unexplained Abuses of Human IgG Subclass Denomination in Antibody Patents
|
Pottier, Jérémy |
|
2014 |
28 |
4 |
p. 327-329 |
artikel |